Cyclerion Therapeutics, Inc. Gains 36.78%
Tue, Jun 23, 2020 at 05:30 PM
Cyclerion Therapeutics, Inc. (CYCN:NASDAQ) rocketted at $7.14, representing a gain of 36.8%. The stock got featured on our News Catalysts scanner on Thu 18 Jun 20 at 05:08 PM in the 'MISCELLANEOUS' category. From Mon 08 Jun 20, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Thu 20 Feb 20 at $6.24 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About Cyclerion Therapeutics, Inc. (CYCN:NASDAQ)
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases.Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators.
Top 10 Gainers:
- Barnwell Industries, Inc. (BRN:NYSEMKT), 73.19%
- Lilis Energy, Inc. (LLEX:NYSEMKT), 63.91%
- Translate Bio, Inc. (TBIO:NASDAQ), 46.98%
- Inovio Pharmaceuticals, Inc. (INO:NASDAQ), 40.98%
- China Rapid Finance Limited (XRF:NYSE), 40.89%
- Seanergy Maritime Holdings Corp. (SHIP:NASDAQ), 40.07%
- Fuwei Films (Holdings) Co., Ltd. (FFHL:NASDAQ), 39.87%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 36.78%
- Urban One, Inc. (UONE:NASDAQ), 34.14%
- Infrastructure and Energy Alternatives, Inc. (IEA:NASDAQ), 25.78%